Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe minimum interval between Mounjaro doses is seven days. Each injection of tirzepatide is designed as a once-weekly medicine, and that seven-day gap is not a rough guide — it is the licensed dosing schedule. Taking a dose sooner than seven days after the last one does not speed up results and significantly raises the risk of side effects, particularly gastrointestinal ones. Your prescriber and the Mounjaro Summary of Product Characteristics on the eMC both confirm this schedule. What varies is whether the day itself can shift slightly, and in what circumstances that is acceptable.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
You started on a Tuesday, then rescheduled to Monday because it fitted better around work, then a bank holiday pushed you to Sunday. Before long you are looking at your pen and wondering whether Friday is too soon. This is one of the most common practical questions our prescribers field, and the answer is grounded in how tirzepatide behaves in the body.
Tirzepatide has a half-life of roughly five days, which is why Eli Lilly designed the schedule around a seven-day window. At that interval, the medicine has reached a stable pattern of presence in the bloodstream. Compress the gap and you are layering a new dose on top of one that has not fully cycled through, the result is a steeper peak concentration, and that is what drives nausea, vomiting and other gastrointestinal effects. The NHS tirzepatide information page describes this GI profile clearly and is worth reading alongside your patient leaflet.
So: seven days is the floor. If you have taken a dose on a Friday and the following week you want to shift permanently to Monday, that is a ten-day gap, fine. Shifting to Thursday would be a nine-day gap, also fine. The adjustment that needs care is shortening the interval below seven days, which the licensed schedule does not permit, and our page on how many days between Mounjaro doses explains the numbers behind that boundary in more detail.
The Mounjaro prescribing information does allow a one-off adjustment to the day of the week, provided at least four days (approximately 96 hours) have passed since the previous injection. This is not a loophole to use regularly; it is a practical allowance for situations like a holiday, a surgical procedure, or a genuine scheduling clash.
Practically, that means if your usual day is Wednesday and you want to move permanently to Saturday, you can do so the first week by injecting on Saturday, as long as the Wednesday injection was at least four days earlier. From the following Saturday, that becomes your new day. What you cannot do is inject on Thursday after a Wednesday dose simply because you forgot, then try to correct it the following week. Irregular short intervals accumulate and disrupt the steady-state balance the titration schedule is designed to build.
If you are unsure whether a particular gap is acceptable, the right move is to contact your prescriber before injecting, not after. At nume, aftercare is available seven days a week precisely so questions like this get a clinical answer in time to be useful. For a fuller look at how the interval relates to overall dose timing, our page on how long to leave between Mounjaro doses covers additional scenarios, including what to do if life pulls your schedule in an unexpected direction and you need to understand how long you can leave between Mounjaro doses before it becomes a clinical concern.
Missing a dose entirely follows a different logic. If you realise within five days of your usual injection day that you have missed it, inject as soon as you remember and then resume your regular weekly schedule from there. Set a new day if needed. But if more than five days have passed since the dose was due, skip it altogether and wait for your next scheduled day.
This is the part that feels counterintuitive. Surely taking a slightly late dose is better than skipping? In most medicines that would be true. With a long-acting weekly injection, the body is already cycling through the previous dose's tail, and a late injection landed too close to the next scheduled one creates the same compression problem described above. Two doses in quick succession is never the right correction.
The broader picture of Mounjaro's dose strengths (from the 2.5mg starter pen through to 15mg) is laid out on our Mounjaro doses page if you want to understand where a missed dose fits within your titration plan. And if the cost of replacing a pen you have accidentally wasted is a concern, our page on the Eli Lilly Mounjaro price increase sets out the current UK pricing context honestly.
People sometimes confuse the minimum time between doses with the minimum time before a dose increase. They are two different things. The weekly interval is fixed. The titration schedule (moving from 2.5mg to 5mg, 5mg to 7.5mg, and so on) is a clinical decision made by your prescriber, typically after a minimum of four weeks at each strength, based on how your body is responding and tolerating treatment.
Rushing titration is not the same as remembering your weekly injection on time. Moving up a strength too soon is one of the drivers of persistent nausea and early dropout. The 2.5mg starting dose exists to let your system adjust gradually, not because it is the therapeutic target. Some people stay at lower doses and do well; others move through the schedule at the standard pace. Either way, that decision belongs to a clinical review, not a calendar calculation.
Mounjaro is a prescription-only medicine, and every dose change at nume is reviewed by a GPhC-registered Independent Prescriber before it is approved. If you are considering your options or want to understand the difference between strengths, our overview of 2.5mg versus 5mg Mounjaro is a good starting point. For anything dose-specific to your own treatment, your prescriber's advice and the patient information leaflet are the definitive references.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.